Optimization of a Saccharomyces cerevisiae fermentation process for production of a therapeutic recombinant protein using a multivariate bayesian approach

Various approaches have been applied to optimize biological product fermentation processes and define design space. In this article, we present a stepwise approach to optimize a Saccharomyces cerevisiae fermentation process through risk assessment analysis, statistical design of experiments (DoE), and multivariate Bayesian predictive approach. The critical process parameters (CPPs) were first identified through a risk assessment. The response surface for each attribute was modeled using the results from the DoE study with consideration given to interactions between CPPs. A multivariate Bayesian predictive approach was then used to identify the region of process operating conditions where all attributes met their specifications simultaneously. The model prediction was verified by twelve consistency runs where all batches achieved broth titer more than 1.53 g/L of broth and quality attributes within the expected ranges. The calculated probability was used to define the reliable operating region. To our knowledge, this is the first case study to implement the multivariate Bayesian predictive approach to the process optimization for the industrial application and its corresponding verification at two different production scales. This approach can be extended to other fermentation process optimizations and reliable operating region quantitation. © 2012 American Institute of Chemical Engineers Biotechnol. Prog., 28: 1095–1105, 2012

[1]  Kimberly Vukovinsky,et al.  Verification of Design Spaces Developed at Subscale , 2012, Journal of Pharmaceutical Innovation.

[2]  Alex Eon-Duval,et al.  Application of Quality by Design to the characterization of the cell culture process of an Fc-Fusion protein. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  R. H. Myers Classical and modern regression with applications , 1986 .

[4]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[5]  Margaret J. Robertson,et al.  Design and Analysis of Experiments , 2006, Handbook of statistics.

[6]  David Lloyd,et al.  An Introduction to Metabolic and Cellular Engineering , 2011 .

[7]  Thomas Ryll,et al.  Development of a scale down cell culture model using multivariate analysis as a qualification tool , 2014, Biotechnology progress.

[8]  Xiangyang Wang,et al.  Defining Process Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation , 2008, Biotechnology progress.

[9]  John J. Peterson A Posterior Predictive Approach to Multiple Response Surface Optimization , 2004 .

[10]  Sonia Cortassa,et al.  Metabolic and Cellular Engineering and Bioprocess Engineering in the Industrial Production of Therapeutic Proteins , 2011 .

[11]  Joseph Moses Juran,et al.  The Non-Pareto Principle; Mea Culpa , 1994 .

[12]  Hiroaki Nagashima,et al.  Application of a quality by design approach to the cell culture process of monoclonal antibody production, resulting in the establishment of a design space. , 2013, Journal of pharmaceutical sciences.

[13]  Gail Sofer,et al.  Process Validation in Manufacturing of Biopharmaceuticals , 2012 .

[14]  Feng Li,et al.  A Systematic Approach for Scale‐Down Model Development and Characterization of Commercial Cell Culture Processes , 2006, Biotechnology progress.

[15]  Suzanne S. Farid,et al.  Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein , 2011, Biotechnology progress.

[16]  Aili Cheng,et al.  Finding Design Space and a Reliable Operating Region Using a Multivariate Bayesian Approach with Experimental Design , 2009 .

[17]  Cleo Kontoravdi,et al.  Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns , 2010, Biotechnology progress.

[18]  John J. Peterson,et al.  A Bayesian Reliability Approach to Multiple Response Optimization with Seemingly Unrelated Regression Models , 2009 .

[19]  Patrick Thompson,et al.  Defining process design space for monoclonal antibody cell culture , 2010, Biotechnology and bioengineering.

[20]  Anurag S Rathore,et al.  Roadmap for implementation of quality by design (QbD) for biotechnology products. , 2009, Trends in biotechnology.

[21]  T. Meuwissen,et al.  Using the Pareto principle in genome-wide breeding value estimation , 2011, Genetics Selection Evolution.